Response to ‘OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population’ by unknown
Zeng et al. Arthritis Research & Therapy 2014, 16:433
http://arthritis-research.com/content/16/5/433LETTERResponse to ‘OPN gene polymorphisms influence
the risk of knee OA and OPN levels in synovial
fluid in a Chinese population’
Chao Zeng, Shu-guang Gao and Guang-hua Lei*
See related research by Jiang et al., http://arthritis-research.com/content/15/1/R3We read with great interest the article by Jiang and col-
leagues in a recent issue of Arthritis Research & Therapy
related to osteopontin (OPN) gene polymorphisms influ-
encing the risk of knee osteoarthritis (OA) and the OPN
levels in synovial fluid in a Chinese population [1]. The
authors showed that the thrombin-cleaved osteopontin
(OPN-N) levels in synovial fluid were positively correlated
to the radiographic severity of OA, which was consistent
with our result [2]. In addition, the group indicated that
OPN-N levels (but not the full-length OPN levels) in syn-
ovial fluid were significantly lower in certain OPN gene
polymorphisms (–443TT and –66GG). We believe this re-
sult was very intriguing to lots of readers. However, the
discussion of this specific part was unclear and deserves
more attention.
For the –443 locus, the authors suggested that –443 T
had a lower promoter activity that could regulate the OPN
gene transcript activity, thus influencing OPN expression.
Similarly, for the –66 locus, overexpression of specificity
protein 1 induced higher promoter activation on a plasmid
carrying the T allele compared with the equivalent plasmid
carrying the G allele that was used to explain their find-
ings. In other words, alleles at polymorphic sites in the
OPN gene influence the OPN level by influencing the
level of promoter activity and characterizing their abil-
ity to bind transcription factors that had been pro-
posed by the authors. Perhaps most puzzling of all,
these explanations actually conflicted with their find-
ings – certain OPN gene polymorphisms of the two
loci (–66, –443) were not associated with full-length
OPN, but with OPN-N.* Correspondence: lgh9640@sina.cn
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months following its publication. After this time
License (http://creativecommons.org/licenses/b
provided the original work is properly cited.Almost at the end of the discussion, the authors postu-
late that the influence of OPN polymorphisms on risk
and severity of OA is very probably due to its effect on
the synthesis of the active OPN protein. Combined with
the result of the study, we speculate that the authors
mean that certain OPN polymorphisms could lead to ac-
tive OPN protein that can easily be cut by thrombin.
However, the loci (–66, –443) are all in the human OPN
promoter, but not the coding sequence. Theoretically, a
promoter is a region of DNA that initiates transcription
of a particular gene that could influence the expression
of this gene but may not have an effect on the properties
of the corresponding protein.
So what are the possible reasons that could explain the
high OPN-N level in OA patients? Liu and coworkers
suggested that significant higher expression of thrombin
was observed in OA synovial fibroblasts than in normal
synovial fibroblasts [3]. Ohba and colleagues found high
levels of thrombin activity in rheumatoid arthritis [4].
Myles and Leung indicated that OPN cleavage by throm-
bin was dependent on both anion-binding exosites in
thrombin that determined the rates and specificity of
thrombin proteolysis [5]. Alongside these potential rea-
sons (higher expression or activity of thrombin), Jones and
colleagues found that antithrombin activity is selectively
depressed in rheumatoid arthritis synovial fibroblasts [6].
Above all, we respect the great contribution of the au-
thors and have no doubt that the results of the data are
accurate. We are just curious about the association be-
tween certain OPN gene polymorphisms and OPN-N
(not full-length OPN). We would be very grateful if the
authors could discuss this association more clearly. The
association between certain OPN gene polymorphisms
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OA: Osteoarthritis; OPN: Osteopontin; OPN-N: Thrombin-cleaved osteopontin.
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